05/31/2012 - 12:56pm

The House of Representatives on Wednesday passed legislation that reauthorizes the Food and Drug Administration’s prescription drug user fee programs that are scheduled to expire in September. H.R. 5651 passed the House by a vote of 387 to 5.

05/31/2012 - 12:49pm

A Johnson & Johnson subsidiary is seeking approval for a Type 2 diabetes treatment.

05/31/2012 - 11:29am

Ric Jurgens spent the past 43 years working for and building Hy-Vee into a strong regional chain, and later this summer his accomplishments will be acknowledged by the Grocery Manufacturers Association when he receives the organization’s Hall of Achievement Award.

05/31/2012 - 11:23am

The Food and Drug Administration on Thursday warned parents against administering benzocaine to their teething babies and advised that parents not use benzocaine at all in children under the age of 2 years unless under the supervision of a family physician.

05/31/2012 - 10:54am

The leader of the country's largest privately owned specialty pharmacy provider is going to Washington, D.C.

05/31/2012 - 8:47am

Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

05/30/2012 - 10:56am

The House of Representatives will be debating H.R. 5651 Wednesday afternoon — a bill that, if passed, will reauthorize the Prescription Drug User Fee Act.

05/30/2012 - 10:39am

A counterfeit version of a Teva Pharmaceutical Industries attention deficit hyperactivity disorder and narcolepsy drug is circulating online, regulators warned Tuesday.

05/30/2012 - 10:26am

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said.